Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects

NCT04053023 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholestasis

Interventions

DRUG: GSK2330672 (linerixibat)
DRUG: Obeticholic acid

Sponsor

GlaxoSmithKline